News
Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...
Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.
An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...
The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...
RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.
U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans ...
Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...
The Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP), and its eight new members, met for the first time Thursday after Health and Humans Services ...
A startling new vision of vaccination in America is becoming clearer — one likely to involve fresh scrutiny of established science and practices, and limits on vaccines that have been studied for ...
The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...
Studies have found important benefits from the new RSV immunization and enhanced versions of the flu shot. Plus, the shingles ...
In recent weeks, Health and Human Services Secretary Robert F. Kennedy Jr. has begun to dismantle decades of vaccine safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results